18 research outputs found
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Immunoglobulin G (IgG) antibodies are crucial for protection against invading pathogens. A highly conserved N-linked glycan within the IgG-Fc tail, which is essential for IgG function, shows variable composition in humans. Afucosylated IgG variants are already used in anticancer therapeutic antibodies for their increased activity through Fc receptors (Fc gamma RIIIa). Here, we report that afucosylated IgG (approximately 6% of total IgG in humans) are specifically formed against enveloped viruses but generally not against other antigens. This mediates stronger Fc gamma RIIIa responses but also amplifies brewing cytokine storms and immune-mediated pathologies. Critically ill COVID-19 patients, but not those with mild symptoms, had high concentrations of afucosylated IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplifying proinflammatory cytokine release and acute phase responses. Thus, antibody glycosylation plays a critical role in immune responses to enveloped viruses, including COVID-19.Proteomic
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages
Patients diagnosed with coronavirus disease 2019 (COVID-19) become critically ill primarily around the time of activation of the adaptive immune response. Here, we provide evidence that antibodies play a role in the worsening of disease at the time of seroconversion. We show that early-phase severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific immunoglobulin G (IgG) in serum of critically ill COVID-19 patients induces excessive inflammatory responses by human alveolar macrophages. We identified that this excessive inflammatory response is dependent on two antibody features that are specific for patients with severe COVID-19. First, inflammation is driven by high titers of anti-spike IgG, a hallmark of severe disease. Second, we found that anti-spike IgG from patients with severe COVID-19 is intrinsically more proinflammatory because of different glycosylation, particularly low fucosylation, of the antibody Fc tail. Low fucosylation of anti-spike IgG was normalized in a few weeks after initial infection with SARS-CoV-2, indicating that the increased antibody-dependent inflammation mainly occurs at the time of seroconversion. We identified Fc gamma receptor (Fc gamma R) Ila and FeyRIII as the two primary IgG receptors that are responsible for the induction of key COVID-19-associated cytokines such as interleukin-6 and tumor necrosis factor. In addition, we show that anti-spike IgG-activated human macrophages can subsequently break pulmonary endothelial barrier integrity and induce microvascular thrombosis in vitro. Last, we demonstrate that the inflammatory response induced by anti-spike IgG can be specifically counteracted by fostamatinib, an FDA- and EMA-approved therapeutic small-molecule inhibitor of Syk kinase.Proteomic
A roadmap for Antarctic and Southern Ocean science for the next two decades and beyond
Antarctic and Southern Ocean science is vital to understanding natural variability, the processes
that govern global change and the role of humans in the Earth and climate system. The potential for new
knowledge to be gained from future Antarctic science is substantial. Therefore, the international Antarctic
community came together to ‘scan the horizon’ to identify the highest priority scientific questions that
researchers should aspire to answer in the next two decades and beyond. Wide consultation was a
fundamental principle for the development of a collective, international view of the most important future
directions in Antarctic science. From the many possibilities, the horizon scan identified 80 key scientific
questions through structured debate, discussion, revision and voting. Questions were clustered into seven
topics: i)Antarctic atmosphere and global connections, ii) Southern Ocean and sea ice in a warming world,
iii) ice sheet and sea level, iv) the dynamic Earth, v) life on the precipice, vi) near-Earth space and beyond,
and vii) human presence in Antarctica. Answering the questions identified by the horizon scan will require
innovative experimental designs, novel applications of technology, invention of next-generation field and
laboratory approaches, and expanded observing systems and networks. Unbiased, non-contaminating
procedures will be required to retrieve the requisite air, biota, sediment, rock, ice and water samples.
Sustained year-round access toAntarctica and the Southern Ocean will be essential to increase winter-time
measurements. Improved models are needed that represent Antarctica and the Southern Ocean in the
Earth System, and provide predictions at spatial and temporal resolutions useful for decision making.
A co-ordinated portfolio of cross-disciplinary science, based on new models of international collaboration,
will be essential as no scientist, programme or nation can realize these aspirations alone.Tinker Foundation, Antarctica New Zealand, The New Zealand
Antarctic Research Institute, the Scientific Committee on
Antarctic Research (SCAR), the Council of Managers of
National Antarctic Programs (COMNAP), the Alfred
Wegner Institut, Helmholtz Zentrum für Polar und
Meeresforschung (Germany), and the British Antarctic
Survey (UK).http://journals.cambridge.org/action/displayJournal?jid=ANShb201
IDH1 mutation is associated with increased telomere length in glioma cells irrespective of WHO grade
Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: A randomized controlled trial
10.1186/s12916-018-1093-8BMC Medicine16110
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
Background Afucosylated IgG1 responses have only been found against membrane-embedded epitopes, including anti-S in SARS-CoV-2 infections. These responses, intrinsically protective through enhanced Fc gamma RIIIa binding, can also trigger exacerbated pro-inflammatory responses in severe COVID-19. We investigated if the BNT162b2 SARS-CoV-2 mRNA also induced afucosylated IgG responses. Methods Blood from vaccinees during the first vaccination wave was collected. Liquid chromatography-Mass spectrometry (LC-MS) was used to study anti-S IgG1 Fc glycoprofiles. Responsiveness of alveolar-like macrophages to produce proinflammatory cytokines in presence of sera and antigen was tested. Antigen-specific B cells were characterized and glycosyltransferase levels were investigated by Fluorescence-Activated Cell Sorting (FACS). Findings Initial transient afucosylated anti-S IgG1 responses were found in naive vaccinees, but not in antigen -experienced ones. All vaccinees had increased galactosylated and sialylated anti-S IgG1. Both naive and antigen -experienced vaccinees showed relatively low macrophage activation potential, as expected, due to the low antibody levels for naive individuals with afucosylated IgG1, and low afucosylation levels for antigen-experienced individuals with high levels of anti-S. Afucosylation levels correlated with FUT8 expression in antigen-specific plasma cells in naive individuals. Interestingly, low fucosylation of anti-S IgG1 upon seroconversion correlated with high anti-S IgG levels after the second dose. Interpretation Here, we show that BNT162b2 mRNA vaccination induces transient afucosylated anti-S IgG1 responses in naive individuals. This observation warrants further studies to elucidate the clinical context in which potent afucosylated responses would be preferred. Copyright (c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)